Stay informed, stay ahead.
For the first time, people in England and Wales will be able to receive a long-acting injection to prevent HIV on the NHS, bringing the policy in line with Scotland. The jab — cabotegravir (CAB-LA) — is taken every two months and offers an alternative to daily PrEP tablets. Health officials hope the rollout will…
The UK’s health watchdog, NICE, has approved ViiV Healthcare’s HIV prevention injection, Apretude, paving the way for its rollout on the National Health Service (NHS) in England and Wales. Apretude, developed by GSK’s ViiV Healthcare unit, is designed for pre-exposure prophylaxis (PrEP) — a treatment that prevents HIV infection in people at high risk. Unlike…
